84 related articles for article (PubMed ID: 8433695)
1. Live virus shows promise as AIDS vaccine.
Minn Med; 1993 Feb; 76(2):52. PubMed ID: 8433695
[No Abstract] [Full Text] [Related]
2. AIDS vaccines show promise in primates.
Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
[No Abstract] [Full Text] [Related]
3. AIDS vaccine developments.
Cranage MP; Ashworth LA; Greenaway PJ; Murphey-Corb M; Desrosiers RC
Nature; 1992 Feb; 355(6362):685-6. PubMed ID: 1741055
[No Abstract] [Full Text] [Related]
4. AIDS vaccine developments.
Osterhaus A; de Vries P; Heeney J
Nature; 1992 Feb; 355(6362):684-5. PubMed ID: 1741054
[No Abstract] [Full Text] [Related]
5. A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32H.
Petry H; Stahl-Hennig C; Dittmer U; Jones D; Farrar G; Wachter H; Fuchs D; Nisslein T; Jurkiewicz E; Hunsmann G; Lüke W
AIDS; 1998 Feb; 12(3):329-30. PubMed ID: 9518000
[No Abstract] [Full Text] [Related]
6. [Live attenuated viruses: a new strategy for vaccination against AIDS].
Molina JM
Pathol Biol (Paris); 1993 Jun; 41(6):513-4. PubMed ID: 8247628
[No Abstract] [Full Text] [Related]
7. Vaccines. Monkey puzzles.
Cohen J
Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
[No Abstract] [Full Text] [Related]
8. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
9. HIV vaccine design: insights from live attenuated SIV vaccines.
Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
[TBL] [Abstract][Full Text] [Related]
10. AIDS vaccine models: challenging challenge viruses.
Feinberg MB; Moore JP
Nat Med; 2002 Mar; 8(3):207-10. PubMed ID: 11875482
[No Abstract] [Full Text] [Related]
11. Attenuated retrovirus vaccines and AIDS.
Van Rompay KK; Spinner A; Otsyula M; McChesney MB; Marthas ML
Science; 1995 Nov; 270(5239):1218-9; author reply 1220-2. PubMed ID: 7502051
[No Abstract] [Full Text] [Related]
12. Mechanism of protection of live attenuated simian immunodeficiency virus: coevolution of viral and immune responses.
Cohen GB
AIDS; 2010 Mar; 24(5):637-48. PubMed ID: 20186034
[No Abstract] [Full Text] [Related]
13. Attenuated retrovirus vaccines and AIDS.
Shearer GM; Lucey DR; Clerici M
Science; 1995 Nov; 270(5239):1219; author reply 1220-2. PubMed ID: 7502053
[No Abstract] [Full Text] [Related]
14. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y
J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746
[TBL] [Abstract][Full Text] [Related]
15. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
[TBL] [Abstract][Full Text] [Related]
16. Radical approach to HIV vaccine.
Nurs Stand; 1992 Sep 30-Oct 6; 7(2):17. PubMed ID: 1419714
[No Abstract] [Full Text] [Related]
17. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
18. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
[TBL] [Abstract][Full Text] [Related]
19. Primate models of AIDS vaccine development.
Lamb-Wharton RJ; Joag SV; Stephens EB; Narayan O
AIDS; 1997; 11 Suppl A():S121-6. PubMed ID: 9451975
[No Abstract] [Full Text] [Related]
20. Humoral immunity to HIV, SIV, and SHIV.
Haigwood NL; Zolla-Pazner S
AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
